Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt repayments

Hims & Hers Health (HIMS) Shares Issued (2019 - 2025)

Hims & Hers Health (HIMS) has disclosed Shares Issued for 6 consecutive years, with -$3.4 million as the latest value for Q4 2025.

Quarterly Shares Issued rose 81.53% to -$3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Dec 2025, up 1833.93% year-over-year, with the annual reading at $6.4 million for FY2025, 1833.93% up from the prior year.
Shares Issued hit -$3.4 million in Q4 2025 for Hims & Hers Health, down from $3.3 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $75.0 million in Q1 2021 to a low of -$74.7 million in Q2 2021.
Historically, Shares Issued has averaged $4.3 million across 5 years, with a median of $1.1 million in 2022.
Biggest YoY gain for Shares Issued was 3519.68% in 2024; the steepest drop was 1398.0% in 2024.
Year by year, Shares Issued stood at $74.4 million in 2021, then plummeted by 101.32% to -$979000.0 in 2022, then surged by 243.0% to $1.4 million in 2023, then crashed by 1398.0% to -$18.2 million in 2024, then skyrocketed by 81.53% to -$3.4 million in 2025.
Business Quant data shows Shares Issued for HIMS at -$3.4 million in Q4 2025, $3.3 million in Q3 2025, and $2.6 million in Q2 2025.